Lobby organisation
UCB
Company · Health & pharma · HQ: Belgium · Transparency Register entry
As of 7 November 2026, UCB appears in 5 declared MEP meetings (4 different MEPs), most often with European People's Party.
In their own words
“UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 9 000 people in approximately 40 countries, the company generated revenue of € 6.1 billion in 2024.”
Read the rest of the statementShow less of the statement
“UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news […]”
Stated goals from the organisation's own Transparency Register filing - the text on file breaks off mid-sentence where marked […].
Who they meet, and when
Which groups they meet
Share of this organisation's 5 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2023–2026. Bar length is relative to its busiest year (4 in 2026). Hatched: 2026 is a part-year - the record runs to 6 Nov 2026.
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 5 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 7 Sep 2026 | Wouter Beke | EU Biotech Act I |
| 4 Sep 2026 | Wouter Beke | EU Biotech Act I |
| 3 Jul 2026 | Olivier Chastel | Politique de Santé de l'UE - Biotech Act |
| 9 Apr 2026 | Angelika Niebler | EU Health Policy |
| 4 Jul 2023 | Andreas Glück | Pharmaceutical legislation |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.